Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of MRG-001 in Wound Healing and Scar Appearance
NCT05844527Phase 2Completed
- Sponsor
- MedRegen LLC
- Start
- Nov 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MRG-001 in surgical wound, scar, sponsored by MedRegen LLC. Started Nov 2023; status: completed.
02
Drugs
MRG-001
03
Conditions
surgical woundscar
Beyond the preview
Go deeper on NCT05844527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05844527.